WO2007066151A3 - Topical compositions for treatment of respiratory disorders - Google Patents

Topical compositions for treatment of respiratory disorders Download PDF

Info

Publication number
WO2007066151A3
WO2007066151A3 PCT/GB2006/050438 GB2006050438W WO2007066151A3 WO 2007066151 A3 WO2007066151 A3 WO 2007066151A3 GB 2006050438 W GB2006050438 W GB 2006050438W WO 2007066151 A3 WO2007066151 A3 WO 2007066151A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
respiratory disorders
topical compositions
compositions
relates
Prior art date
Application number
PCT/GB2006/050438
Other languages
French (fr)
Other versions
WO2007066151A2 (en
Inventor
John Staniforth
Paul Goggin
Original Assignee
Pharmakodex Ltd
John Staniforth
Paul Goggin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmakodex Ltd, John Staniforth, Paul Goggin filed Critical Pharmakodex Ltd
Publication of WO2007066151A2 publication Critical patent/WO2007066151A2/en
Publication of WO2007066151A3 publication Critical patent/WO2007066151A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to compositions for the treatment or prevention of asthma or other respiratory disorders by transdermal administration of a therapeutic agent. In particular, the invention relates to compositions for treating mammalian patients, including human neonates, infants or young children.
PCT/GB2006/050438 2005-12-07 2006-12-07 Topical compositions for treatment of respiratory disorders WO2007066151A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0524959A GB0524959D0 (en) 2005-12-07 2005-12-07 Topical compositions for treatment of respiratory disorders
GB0524959.4 2005-12-07

Publications (2)

Publication Number Publication Date
WO2007066151A2 WO2007066151A2 (en) 2007-06-14
WO2007066151A3 true WO2007066151A3 (en) 2008-03-27

Family

ID=35735705

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/050438 WO2007066151A2 (en) 2005-12-07 2006-12-07 Topical compositions for treatment of respiratory disorders

Country Status (2)

Country Link
GB (1) GB0524959D0 (en)
WO (1) WO2007066151A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202009010937U1 (en) 2008-09-04 2010-02-11 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Monoterpenes for the treatment of respiratory diseases, in particular bronchopulmonary diseases
ITTO20130663A1 (en) * 2013-08-02 2015-02-03 Abc Farmaceutici S P A TRANSDERMIC ADMINISTRATION SYSTEM FOR USE IN THE TREATMENT OF CHRONIC BRONCO-POLMONARY PATHOLOGIES

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189861A2 (en) * 1985-01-26 1986-08-06 Showa Denko Kabushiki Kaisha Percutaneous absorption accelerator for ionic water-soluble medicine
JPS61204117A (en) * 1985-03-07 1986-09-10 Tooa Eiyoo Kk Percutaneous absorption pharmaceutical for external use
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions
WO1993019708A1 (en) * 1992-03-31 1993-10-14 Tbs Laboratories, Inc. Transdermal albuterol absorption dosage unit and process
WO1996014069A1 (en) * 1994-11-04 1996-05-17 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable patch
US5602165A (en) * 1987-12-10 1997-02-11 Kyorin Seiyaku Kabushiki Kaisha Transdermal absorptive drug formulation
US6211425B1 (en) * 1996-10-04 2001-04-03 Saitama Daiichi Seiyaku Kabushiki Kaisha Patch
WO2002000203A1 (en) * 2000-06-26 2002-01-03 Vectura Limited Topical pharmaceutical formulations and methods of treatment
WO2003018102A2 (en) * 2001-08-29 2003-03-06 Vectura Limited Topical administration device

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189861A2 (en) * 1985-01-26 1986-08-06 Showa Denko Kabushiki Kaisha Percutaneous absorption accelerator for ionic water-soluble medicine
JPS61204117A (en) * 1985-03-07 1986-09-10 Tooa Eiyoo Kk Percutaneous absorption pharmaceutical for external use
US5602165A (en) * 1987-12-10 1997-02-11 Kyorin Seiyaku Kabushiki Kaisha Transdermal absorptive drug formulation
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions
WO1993019708A1 (en) * 1992-03-31 1993-10-14 Tbs Laboratories, Inc. Transdermal albuterol absorption dosage unit and process
WO1996014069A1 (en) * 1994-11-04 1996-05-17 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable patch
US6211425B1 (en) * 1996-10-04 2001-04-03 Saitama Daiichi Seiyaku Kabushiki Kaisha Patch
WO2002000203A1 (en) * 2000-06-26 2002-01-03 Vectura Limited Topical pharmaceutical formulations and methods of treatment
WO2003018102A2 (en) * 2001-08-29 2003-03-06 Vectura Limited Topical administration device

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 198643, Derwent World Patents Index; AN 1986-281103, XP002454511 *
DATABASE WPI Week 199625, Derwent World Patents Index; AN 1996-251541, XP002454573 *

Also Published As

Publication number Publication date
WO2007066151A2 (en) 2007-06-14
GB0524959D0 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
HK1146485A1 (en)
WO2008134828A8 (en) Tissue degeneration protection
ATE453642T1 (en) SUBSTITUTED PHENYLAMINOPYRIMIDINES
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
WO2007082068A3 (en) Methods and compositions for treating asthma in human and non human primates
TW200724532A (en) Pyrimidinecarboxylic acid derivatives and their use
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EP2305640A3 (en) Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases
DE502005006149D1 (en) HETARYLOXY-SUBSTITUTED PHENYLAMINOPYRIMIDINES AS RHO-KINASE HEMMER
NO20072920L (en) Combination of Methylxanthine Compounds and Steroids to Treat Chronic Respiratory Diseases
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
WO2009106991A3 (en) Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
NO20082044L (en) Combination therapy including substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders
TW200621765A (en) Substituted phenylaminothiazoles and their use
WO2007098089A3 (en) Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
WO2011005811A8 (en) Combination therapy for the treatment of diabetes
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
NO20054767L (en) Compositions comprising apomorphine for lung inhalation
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
WO2011085256A3 (en) Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
WO2005058935A3 (en) Aqueous suspensions of ciclesonide for nebulisation
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
TW200724146A (en) Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
EP1838316A4 (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
PT2380569T (en) Osmolyte for reduction of side effects of steroids or antihistaminica

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06820664

Country of ref document: EP

Kind code of ref document: A2